Ahlenstiel C - Search Results

1

Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2.

Bowden-Reid E, Ledger S, Zhang Y, Di Giallonardo F, Aggarwal A, Stella AO, Akerman A, Milogiannakis V, Walker G, Rawlinson W, Turville S, Kelleher AD, Ahlenstiel C. Bowden-Reid E, et al. Among authors: ahlenstiel c. Antiviral Res. 2023 Sep;217:105677. doi: 10.1016/j.antiviral.2023.105677. Epub 2023 Jul 20. Antiviral Res. 2023. PMID: 37478918 Free article.

2

Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract.

Zhang Y, Almazi JG, Ong HX, Johansen MD, Ledger S, Traini D, Hansbro PM, Kelleher AD, Ahlenstiel CL. Zhang Y, et al. Int J Mol Sci. 2022 Feb 22;23(5):2408. doi: 10.3390/ijms23052408. Int J Mol Sci. 2022. PMID: 35269550 Free PMC article. Review.

3

Targeted Nanocarrier Delivery of RNA Therapeutics to Control HIV Infection.

Agbosu EE, Ledger S, Kelleher AD, Wen J, Ahlenstiel CL. Agbosu EE, et al. Among authors: ahlenstiel cl. Pharmaceutics. 2022 Jun 26;14(7):1352. doi: 10.3390/pharmaceutics14071352. Pharmaceutics. 2022. PMID: 35890248 Free PMC article. Review.

4

Layer-by-Layer Particles Deliver Epigenetic Silencing siRNA to HIV-1 Latent Reservoir Cell Types.

Czuba-Wojnilowicz E, Klemm V, Cortez-Jugo C, Turville S, Aggarwal A, Caruso F, Kelleher AD, Ahlenstiel CL. Czuba-Wojnilowicz E, et al. Among authors: ahlenstiel cl. Mol Pharm. 2023 Apr 3;20(4):2039-2052. doi: 10.1021/acs.molpharmaceut.2c01030. Epub 2023 Feb 27. Mol Pharm. 2023. PMID: 36848493

5

Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus.

Méndez C, Ahlenstiel CL, Kelleher AD. Méndez C, et al. Among authors: ahlenstiel cl. World J Virol. 2015 Aug 12;4(3):219-44. doi: 10.5501/wjv.v4.i3.219. World J Virol. 2015. PMID: 26279984 Free PMC article. Review.

6

Novel RNA Duplex Locks HIV-1 in a Latent State via Chromatin-mediated Transcriptional Silencing.

Ahlenstiel C, Mendez C, Lim ST, Marks K, Turville S, Cooper DA, Kelleher AD, Suzuki K. Ahlenstiel C, et al. Mol Ther Nucleic Acids. 2015 Oct 27;4(10):e261. doi: 10.1038/mtna.2015.31. Mol Ther Nucleic Acids. 2015. PMID: 26506039 Free PMC article.

7

RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency.

Méndez C, Ledger S, Petoumenos K, Ahlenstiel C, Kelleher AD. Méndez C, et al. Among authors: ahlenstiel c. Retrovirology. 2018 Oct 4;15(1):67. doi: 10.1186/s12977-018-0451-0. Retrovirology. 2018. PMID: 30286764 Free PMC article.

8

Delivery of gene therapy to resting immune cells for an HIV cure.

Ahlenstiel CL, Turville SG. Ahlenstiel CL, et al. Curr Opin HIV AIDS. 2019 Mar;14(2):129-136. doi: 10.1097/COH.0000000000000531. Curr Opin HIV AIDS. 2019. PMID: 30608248 Review.

9

RNAi therapeutics: an antiviral strategy for human infections.

Kelleher AD, Cortez-Jugo C, Cavalieri F, Qu Y, Glanville AR, Caruso F, Symonds G, Ahlenstiel CL. Kelleher AD, et al. Among authors: ahlenstiel cl. Curr Opin Pharmacol. 2020 Oct;54:121-129. doi: 10.1016/j.coph.2020.09.011. Epub 2020 Nov 7. Curr Opin Pharmacol. 2020. PMID: 33171339 Review.

10

The feasibility of incorporating Vpx into lentiviral gene therapy vectors.

McAllery SA, Ahlenstiel CL, Suzuki K, Symonds GP, Kelleher AD, Turville SG. McAllery SA, et al. Mol Ther Methods Clin Dev. 2016 Oct 19;5:16066. doi: 10.1038/mtm.2016.66. eCollection 2016. Mol Ther Methods Clin Dev. 2016. PMID: 27790625 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters